| MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy (NCT05333367) | Centre Hospitalier Universitaire de Besancon | 2022-04-15 |
| Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation. (NCT04851145) | University Hospital, Bordeaux | 2021-11-08 |
| Urine Biomarker for Kidney Transplant Rejection (NCT05072951) | Exosome Diagnostics, Inc. | 2021-10-01 |
| Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation (NCT04488094) | Asan Medical Center | 2020-11-18 |
| Molecular HistoMx Assessment for Kidney Transplant Rejection and Management (NCT07347353) | Paris Translational Research Center for Organ Transplantation | 2020-02-01 |
| Study of the Pathogenicity and Humoral Immune Response Induced by BK Virus in Lung Transplant Recipients (NCT04164576) | University Hospital, Strasbourg, France | 2020-01-01 |
| The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation (NCT03147157) | The First Hospital of Jilin University | 2017-05-01 |
| Regenerative Cellular Therapies, Physiology, Pathology and Developmental Biology (NCT02469207) | Cambridge University Hospitals NHS Foundation Trust | 2016-01-01 |
| A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection (NCT01147302) | Shire | 2011-08-24 |
| Pathogenetic Risk Factors for Corneal Graft Rejection (NCT06281587) | The S.N. Fyodorov Eye Microsurgery State Institution | 2011-01-01 |
| Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation (NCT01035593) | Pharming Technologies B.V. | 2010-12-01 |
| Montelukast in Bronchiolitis Obliterans Syndrome (NCT01211509) | Universitaire Ziekenhuizen KU Leuven | 2010-10-01 |
| Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients (NCT00895583) | Pfizer | 2009-06-01 |
| Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation (NCT00807144) | Imperial College Healthcare NHS Trust | 2008-12-01 |
| Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation (NCT01066689) | University Hospital, Tours | 2008-10-01 |
| Randomized Trial for Mixed Acute Rejection (NCT00771875) | University of Cincinnati | 2008-09-01 |
| Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol (NCT00706680) | University Health Network, Toronto | 2008-02-01 |
| HLA-Identical Sibling Renal Transplant Tolerance (NCT00619528) | Northwestern University | 2008-01-01 |
| Study of Rituximab to Treat Chronic Renal Transplant Rejection (NCT00476164) | King's College London | 2007-01-01 |
| Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients (NCT00369382) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| A Study on a New Staining Method (C4d Staining) of Transplanted Kidney Biopsies (NCT00498095) | Hospital Authority, Hong Kong | 2006-07-01 |
| Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection (NCT00300274) | Novartis Pharmaceuticals | 2006-01-01 |
| Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients (NCT00251004) | Novartis | 2005-10-01 |
| Azithromycin in Bronchiolitis Obliterans Syndrome (NCT01009619) | KU Leuven | 2005-09-01 |
| Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY (NCT00761787) | XDx | 2005-05-01 |
| Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants (NCT00106925) | National Heart, Lung, and Blood Institute (NHLBI) | 2005-04-22 |
| Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation (NCT00331162) | Wake Forest University Health Sciences | 2005-02-01 |
| IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection (NCT00351559) | XDx | 2005-01-01 |
| Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy (NCT00097968) | Novartis Pharmaceuticals | 2004-08-01 |
| Lung Allograft Rejection Gene Expression Observational (LARGO) Study (NCT00751309) | XDx | 2004-04-01 |
| Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients (NCT00266123) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-03-01 |
| A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection (NCT00089947) | Genzyme, a Sanofi Company | 2003-06-01 |
| Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients (NCT00254709) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-10-01 |
| Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients (NCT00273871) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-01-01 |
| Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney (NCT00035555) | Bristol-Myers Squibb | 2001-03-01 |
| Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys (NCT00001984) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1999-11-01 |
| Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants (NCT00001858) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1999-06-08 |
| A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure (NCT00510913) | Astellas Pharma Inc | 1999-02-01 |
| Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty (NCT00450996) | University of Erlangen-Nürnberg Medical School | 1999-01-01 |
| Collaborative Corneal Transplantation Studies (CCTS) (NCT00000137) | National Eye Institute (NEI) | 1986-05-01 |
| Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA) (NCT00290069) | Sociedad Andaluza de Trasplantes de Organos y Tejidos | |
| Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients (NCT00261820) | Wyeth is now a wholly owned subsidiary of Pfizer | |